Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 15 of 15 entries
View as:

Proof of Concept Study to Assess the Efficacy, Safety of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Phase: N/A Priority: Normal
NCT ID: NCT06051357 Org: User:
Start: 11/15/23 End: 03/25/24 Due: 03/25/25

Efficacy and Safety of HRS-5965 in Patients With PNH Who Are Still Anemia After Anti-C5 Antibody Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06715943 Org: User:
Start: 12/12/24 End: 12/31/25 Due: 12/31/26

A Trial of HRS-5965 Capsule in Primary IgA Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT07014826 Org: User:
Start: 06/30/25 End: 12/31/28 Due: 12/31/29

A Trial of HRS-5965 Tablets in Primary IgA Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT06137768 Org: User:
Start: 12/19/23 End: 08/31/25 Due: 08/31/26

A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism

Phase: N/A Priority: Normal
NCT ID: NCT04994080 Org: User:
Start: 02/01/22 End: 03/31/23 Due: 03/31/24

Investigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT07040787 Org: User:
Start: 07/31/25 End: 08/31/25 Due: 08/31/26

A Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profiles of HRS-5965 Capsules in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT07035665 Org: User:
Start: 06/30/25 End: 07/30/25 Due: 07/30/26

Comparison of HRS-5965 Capsules and Tablets in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06490991 Org: User:
Start: 07/17/24 End: 12/31/24 Due: 12/31/25

Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HRS-5965 in Subjects With Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT06674915 Org: User:
Start: 11/26/24 End: 03/31/25 Due: 03/31/26

Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Phase: N/A Priority: Normal
NCT ID: NCT06238544 Org: User:
Start: 02/06/24 End: 12/31/27 Due: 12/31/28

Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT05505955 Org: User:
Start: 10/08/22 End: 11/03/23 Due: 11/03/24

A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)

Phase: N/A Priority: Normal
NCT ID: NCT05905458 Org: User:
Start: 07/28/23 End: 11/22/24 Due: 11/22/25

A Study to Evaluate the Efficacy and Safety of Oral HRS-5965 in Adult Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06593938 Org: User:
Start: 10/25/24 End: 12/30/25 Due: 12/30/26

A Study to Evaluate the Mass Balance of [14C] HRS-5965 in Healthy Adult Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06567392 Org: User:
Start: 09/03/24 End: 10/08/24 Due: 10/08/25

A Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Study, and QT Interval Study of HRS-5965 Capsules in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06684041 Org: User:
Start: 11/09/24 End: 05/31/25 Due: 05/31/26